The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.

Recruiting now

Conditions studied: Cancer

In brief

The purpose of the Texas Immuno-Oncology Biorepository (TIOB) is to collect and store well-defined and well-annotated serial biospecimens of tissue, blood, urine and stool in a longitudinal manner from cancer patients who are receiving either standard of care surgical interventions and or FDA approved immunotherapeutics across the largest not-for-profit health system in Texas. Comprehensive clinical and radiological data from a diverse population of patients with different racial, social and ethnic backgrounds matched with serial biospecimens over a patients journey with cancer marks the TIOB as a unique research facility.

Key facts

Study ID

NCT05371756

Run by

Baylor Research Institute

People needed

10000

Starts

2020-09-11

Expected to finish

2050-09-11

Last updated by the study team

2026-03-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participant is over 18 years of age at the time of signing the informed consent form.
• Participant is able and willing to sign an informed consent form.
• Participant is suspected by a provider of being at risk for developing cancer,
• OR
• Participant has confirmed or clinically suspected malignancy by a provider. This includes but is not limited to:
• Participants who may be candidates for or are scheduled to receive standard of care immunotherapy treatment for the first time for their current cancer diagnosis, regardless of any prior non-immunotherapy treatment.
• Participants who are enrolled in a clinical trial to receive an investigational, novel immunotherapy drug for the first time for their current cancer diagnosis.
• Participants who may be surgical candidates for their current cancer diagnosis, regardless of any prior treatment.

You may not qualify if…

• Participant is unable or unwilling to donate blood.
• Concurrent medical or psychiatric condition or disease that may compromise the ability to give documented informed consent, is likely to interfere with study procedures or results, or that in the opinion of the investigator would constitute a hazard for participating in this study.

Where it is running

• Baylor Scott & White Medical Center - College Station — College Station, Texas, United States (enrolling)
• Baylor University Medical Center - Dallas — Dallas, Texas, United States (enrolling)
• Baylor Scott & White All Saints Medical Center - Fort Worth — Fort Worth, Texas, United States (enrolling)
• Baylor Scott & White Medical Center - Plano — Plano, Texas, United States (enrolling)
• Baylor Scott & White Medical Center - Round Rock — Round Rock, Texas, United States (enrolling)
• Baylor Scott & White Medical Center - Temple — Temple, Texas, United States (enrolling)
• Baylor Scott & White Medical Center - Hillcrest — Waco, Texas, United States (enrolling)
• Baylor Scott & White Medical Center - Waxahachie — Waxahachie, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.